The Charité Artificial Disc is the first commercially available motion-preserving technology for the lumbar spine. The Charité is the first US Food and Drug Administration-approved artificial disc for the treatment of single-level lumbar degenerative disc disease from L4 to S1. With thousands of implantations worldwide since 1987, it has the longest clinical experience of any artificial disc. No other artificial disc has the substantial preclinical and clinical history that validates its use.